Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial-Reference-Cited by-同舟云学术

Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial

Published:2016-09 Issue:9 Volume:13 Page:1568-1574
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Balekian Alex A.,Tanner Nichole T.,Fisher Joshua M.,Silvestri Gerard A.,Gould Michael K.

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference22 articles.

1. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2012 incidence and mortality web-based report. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2015.

2. Lung Cancer Screening: The Mayo Program

3. Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation

4. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography

5. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program;European Radiology;2023-11-03

2. Overcoming barriers to lung cancer screening using a systemwide approach with additional focus on the non-screened;Journal of Medical Screening;2023-10-19

3. Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard;European Respiratory Journal;2023-05-18

4. Effect of prior pulmonary TB on low-dose computed tomography during lung cancer screening;The International Journal of Tuberculosis and Lung Disease;2023-03-01

5. Comorbidity and life expectancy in shared decision making for lung cancer screening;Seminars in Oncology;2022-06